These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1988897)

  • 1. Mid-second-trimester labor induction: concentrated oxytocin compared with prostaglandin E2 vaginal suppositories.
    Winkler CL; Gray SE; Hauth JC; Owen J; Tucker JM
    Obstet Gynecol; 1991 Feb; 77(2):297-300. PubMed ID: 1988897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentrated oxytocin plus low-dose prostaglandin E2 compared with prostaglandin E2 vaginal suppositories for second-trimester pregnancy termination.
    Owen J; Hauth JC
    Obstet Gynecol; 1996 Jul; 88(1):110-3. PubMed ID: 8684741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second trimester pregnancy termination including fetal death: comparison of five different methods.
    Yapar EG; Senöz S; Urkütür M; Batioglu S; Gökmen O
    Eur J Obstet Gynecol Reprod Biol; 1996 Nov; 69(2):97-102. PubMed ID: 8902440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second-trimester labor induction.
    Ramsey PS; Savage K; Lincoln T; Owen J
    Obstet Gynecol; 2004 Jul; 104(1):138-45. PubMed ID: 15229013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midtrimester pregnancy termination: a randomized trial of prostaglandin E2 versus concentrated oxytocin.
    Owen J; Hauth JC; Winkler CL; Gray SE
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 1):1112-6. PubMed ID: 1384335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E2 suppositories as a second-trimester abortifacient.
    Rakhshani R; Grimes DA
    J Reprod Med; 1988 Oct; 33(10):817-20. PubMed ID: 3193412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E2 induction of abortion and fetal demise.
    Wiley TL; Poole CP; Gookin KS; Wiser WL; Morrison JC
    Int J Gynaecol Obstet; 1989 Feb; 28(2):171-5. PubMed ID: 2563705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midtrimester pregnancy termination for fetal malformations. Use of intravaginal prostaglandin E2.
    Hagar DL; Valley MT; Rayburn WF; Carey JC
    J Reprod Med; 1997 Aug; 42(8):497-500. PubMed ID: 9284011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of 16,16-dimethyl-trans delta 2 prostaglandin E1 methyl ester (gemeprost) vaginal pessaries for the termination of pregnancy in the early second trimester. A comparison with extra-amniotic prostaglandin E2.
    Cameron IT; Baird DT
    Br J Obstet Gynaecol; 1984 Nov; 91(11):1136-40. PubMed ID: 6594157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of the third stage of labor in pregnancies terminated by prostaglandin E2.
    Kirz DS; Haag MK
    Am J Obstet Gynecol; 1989 Feb; 160(2):412-4. PubMed ID: 2916627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second trimester abortion using prostaglandin E2 suppositories with or without intracervical Laminaria japonica: a randomized study.
    Atlas RO; Lemus J; Reed J; Atkins D; Alger LS
    Obstet Gynecol; 1998 Sep; 92(3):398-402. PubMed ID: 9721778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal misoprostol vs. concentrated oxytocin plus low-dose prostaglandin E2 for second trimester pregnancy termination.
    Owen J; Hauth JC
    J Matern Fetal Med; 1999; 8(2):48-50. PubMed ID: 10090490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mid-trimester termination of pregnancy with 16,16-dimethyl-trans-delta 2 PGE1 vaginal pessaries: a comparison with intra- and extra-amniotic prostaglandin E2 administration.
    Hill NC; Selinger M; Ferguson J; MacKenzie IZ
    Int J Gynaecol Obstet; 1991 Aug; 35(4):337-40. PubMed ID: 1682182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second-trimester membrane rupture. Abortion induced with prostaglandin E2 after oxytocin failure.
    Atad J; Hallak M; Fruchter O; Borenstein J; Abramovici H
    J Reprod Med; 1997 Sep; 42(9):581-4. PubMed ID: 9336755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mid-trimester abortion induced by intravaginal administration of prostaglandin E2 suppositories.
    Lauersen NH; Secher NJ; Wilson KH
    Am J Obstet Gynecol; 1975 Aug; 122(8):947-54. PubMed ID: 1155530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of ethacridine lactate and prostaglandin E2 in second trimester medical abortion.
    Inan I; Kelekçi S; Yazar D
    Acta Obstet Gynecol Scand; 1997 Aug; 76(7):680-3. PubMed ID: 9292644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letter: Intravenous prostaglandins and oxytocin for mid-trimester abortion.
    Coltart TM; Coe MJ
    Lancet; 1975 Jan; 1(7899):173-4. PubMed ID: 46097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mid-trimester abortion using hypertonic saline or prostaglandin E2 gel: an analysis of efficacy and complications.
    Herabutya Y; O-Prasertsawat P
    J Med Assoc Thai; 1994 Mar; 77(3):148-52. PubMed ID: 7798849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Premature termination of pregnancy in the 2nd and 3rd trimester. Serial administration of 1 mg gemeprost vaginal suppositories versus intravenous sulproston].
    Müller T; Backe J; Rempen A
    Geburtshilfe Frauenheilkd; 1996 May; 56(5):234-8. PubMed ID: 8768060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The use of prostaglandin E2 to induce labor and abortion in the second trimester].
    Khadzhiev A
    Akush Ginekol (Sofiia); 1991; 30(1):39-45. PubMed ID: 1793135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.